Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2025 10:44 ET | Source: HNL Lab Medicine

HNL Lab Medicine Introduces Self-Collected HPV Test to Increase Privacy and Access

HNL Lab Medicine offers a new self-collected HPV test that detects 14 high-risk strains, all while enhancing patient privacy and convenience.
September 17, 2025 07:00 ET | Source: Microbix Biosystems Inc.

Microbix Client Labquality Introduces Novel EQA Scheme at ESCV

MISSISSAUGA, Ontario and HELSINKI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and...
July 25, 2025 10:07 ET | Source: Research and Markets

8MM Head and Neck Squamous Cell Carcinoma Epidemiology Forecast Research Report 2024-2034 | Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma: Epidemiology Forecast to 2034" report has been added to ResearchAndMarkets.com's offering.This report provides...
March 17, 2025 07:00 ET | Source: Microbix Biosystems Inc.

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

MISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter,...
January 24, 2025 17:34 ET | Source: Tevogen Bio Inc

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target...
November 21, 2024 08:30 ET | Source: Dyadic International, Inc.

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates...
November 05, 2024 09:27 ET | Source: Tevogen Bio Inc

Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920

Tevogen Bio begins pre-clinical effort for TVGN 920, signaling the start of its oncology treatment pipeline.Tevogen Bio created a data set containing known proteins in the HPV genome to identify...
October 15, 2024 14:30 ET | Source: Tevogen Bio Inc

Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions

Approximately one in three women remain HPV positive after cervical procedures for precancerous lesions.Tens of thousands of women in the US each year are diagnosed with high-grade cervical...
May 13, 2024 08:00 ET | Source: Barinthus Biotherapeutics

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
April 18, 2024 16:10 ET | Source: Barinthus Biotherapeutics

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections

Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today announced topline final data from the APOLLO trial (also known as HPV001).